352 related articles for article (PubMed ID: 16547692)
21. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.
Chan TM; Tse KC; Tang CS; Lai KN; Li FK
Lupus; 2005; 14(4):265-72. PubMed ID: 15864912
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
24. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
25. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
Fischer-Betz R; Chehab G; Sander O; Vordenbäumen S; Voiculescu A; Brinks R; Schneider M
J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
[TBL] [Abstract][Full Text] [Related]
26. A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.
Vanthuyne M; Blockmans D; Westhovens R; Roufosse F; Cogan E; Coche E; Nzeusseu Toukap A; Depresseux G; Houssiau FA
Clin Exp Rheumatol; 2007; 25(2):287-92. PubMed ID: 17543155
[TBL] [Abstract][Full Text] [Related]
27. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
Benenson E; Fries JW; Heilig B; Pollok M; Rubbert A
Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
[TBL] [Abstract][Full Text] [Related]
28. Overwhelming septic cavernous sinus thrombosis in a woman after combination of high-dose steroid and intravenous cyclophosphamide therapy for lupus nephritis.
Chen YC; Cheng TT; Lai HM; Wu CH
Lupus; 2000; 9(1):78-9. PubMed ID: 10713653
[TBL] [Abstract][Full Text] [Related]
29. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
Mehra S; Usdadiya JB; Jain VK; Misra DP; Negi VS
Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636
[TBL] [Abstract][Full Text] [Related]
30. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.
Mok CC; Ho CT; Siu YP; Chan KW; Kwan TH; Lau CS; Wong RW; Au TC
Am J Kidney Dis; 2001 Aug; 38(2):256-64. PubMed ID: 11479150
[TBL] [Abstract][Full Text] [Related]
31. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience.
Sabry A; Abo-Zenah H; Medhat T; Sheashaa H; Mahmoud K; El-Huseini A
Int Urol Nephrol; 2009; 41(1):153-61. PubMed ID: 18214709
[TBL] [Abstract][Full Text] [Related]
33. Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey.
Ozbalkan Z; Kiraz S; Ozturk MA; Ertenli AI; Apras S; Calguneri M
Clin Rheumatol; 2006 May; 25(3):358-63. PubMed ID: 16362442
[TBL] [Abstract][Full Text] [Related]
34. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Cauli A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Ann Rheum Dis; 2010 Jan; 69(1):61-4. PubMed ID: 19155235
[TBL] [Abstract][Full Text] [Related]
35. Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
Illei GG; Yarboro CH; Kuroiwa T; Schlimgen R; Austin HA; Tisdale JF; Chitkara P; Fleisher T; Klippel JH; Balow JE; Boumpas DT
Rheumatology (Oxford); 2007 Jun; 46(6):952-6. PubMed ID: 17317716
[TBL] [Abstract][Full Text] [Related]
36. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
37. Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study.
Sigdel MR; Kafle MP; Shah DS
BMC Nephrol; 2016 Oct; 17(1):145. PubMed ID: 27717323
[TBL] [Abstract][Full Text] [Related]
38. Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience.
Das U; Dakshina Murty KV; Prasad N; Prayag A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):372-8. PubMed ID: 20228536
[TBL] [Abstract][Full Text] [Related]
39. Short-interval lower-dose intravenous cyclophosphamide as induction and maintenance therapy for lupus nephritis: a prospective observational study.
Zhang XW; Li C; Ma XX; Zhao JX; An Y; Liu S; Li Y; Li ZG
Clin Rheumatol; 2014 Jul; 33(7):939-45. PubMed ID: 24744152
[TBL] [Abstract][Full Text] [Related]
40. Prednisone in lupus nephritis: how much is enough?
Ruiz-Irastorza G; Danza A; Perales I; Villar I; Garcia M; Delgado S; Khamashta M
Autoimmun Rev; 2014 Feb; 13(2):206-14. PubMed ID: 24189280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
